Please login to the form below

Not currently logged in
Email:
Password:

Cirara

This page shows the latest Cirara news and features for those working in and with pharma, biotech and healthcare.

Biogen wins European spinal muscular atrophy first

Biogen wins European spinal muscular atrophy first

To that end it recently bought late-stage stroke candidate Cirara (glyburide) from Remedy Pharma and an anti-tau antibody from Bristol-Myers Squibb for Alzheimer's disease.

Latest news

  • Biogen hands out $120m upfront for Remedy stroke drug Biogen hands out $120m upfront for Remedy stroke drug

    Cirara vying to be first new treatment since the 1990s. Biogen has added to its late-stage pipeline with a licensing deal for Remedy Pharmaceuticals' Cirara, a drug candidate en route ... Cirara (RP-1127) is an intravenous formulation of glyburide, a

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...

Infographics